Favorable regulations and high patient volumes to augment growth rates
SINGAPORE, March 26, 2018 /PRNewswire/ -- Frost & Sullivan's latest analysis of the APAC biosimilars
Growth Capitalist (https://growthcapitalist.com/2018/03/frost-sullivan-patent-expiries-boost-growth-opportunities-for-apac-biosimilars-market/)
Favorable regulations and high patient volumes to augment growth rates
SINGAPORE, March 26, 2018 /PRNewswire/ -- Frost & Sullivan's latest analysis of the APAC biosimilars